IT1282943B1 - Composizione farmaceutica iniettabile__a base di acido ursodesossicoli co o tauroursodesossicolico - Google Patents

Composizione farmaceutica iniettabile__a base di acido ursodesossicoli co o tauroursodesossicolico

Info

Publication number
IT1282943B1
IT1282943B1 IT95MI002763A ITMI952763A IT1282943B1 IT 1282943 B1 IT1282943 B1 IT 1282943B1 IT 95MI002763 A IT95MI002763 A IT 95MI002763A IT MI952763 A ITMI952763 A IT MI952763A IT 1282943 B1 IT1282943 B1 IT 1282943B1
Authority
IT
Italy
Prior art keywords
ursodexoxicol
tauroursodexoxicolic
acid
pharmaceutical composition
injectable pharmaceutical
Prior art date
Application number
IT95MI002763A
Other languages
English (en)
Inventor
Tiziano Prato
Anna Giulia Rusticali
Original Assignee
Sanofi Winthrop S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Winthrop S P A filed Critical Sanofi Winthrop S P A
Priority to IT95MI002763A priority Critical patent/IT1282943B1/it
Publication of ITMI952763A0 publication Critical patent/ITMI952763A0/it
Priority to PCT/FR1996/002083 priority patent/WO1997024125A2/fr
Priority to US09/091,706 priority patent/US5955456A/en
Priority to EP96944084A priority patent/EP0920320A2/fr
Priority to JP9524071A priority patent/JP2000509013A/ja
Priority to CA002240266A priority patent/CA2240266A1/en
Priority to AU13803/97A priority patent/AU1380397A/en
Publication of ITMI952763A1 publication Critical patent/ITMI952763A1/it
Application granted granted Critical
Publication of IT1282943B1 publication Critical patent/IT1282943B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Exhaust Silencers (AREA)
IT95MI002763A 1995-12-27 1995-12-27 Composizione farmaceutica iniettabile__a base di acido ursodesossicoli co o tauroursodesossicolico IT1282943B1 (it)

Priority Applications (7)

Application Number Priority Date Filing Date Title
IT95MI002763A IT1282943B1 (it) 1995-12-27 1995-12-27 Composizione farmaceutica iniettabile__a base di acido ursodesossicoli co o tauroursodesossicolico
PCT/FR1996/002083 WO1997024125A2 (fr) 1995-12-27 1996-12-26 Composition pharmaceutique injectable contenant l'acide ursodesoxycholique ou l'acide tauroursodesoxycholique, une base forte et du trometamol
US09/091,706 US5955456A (en) 1995-12-27 1996-12-26 Injectable pharmaceutical composition comprising ursodesoxycholic acid or tauroursodesoxycholic acid, a strong base and tromethamol
EP96944084A EP0920320A2 (fr) 1995-12-27 1996-12-26 Composition pharmaceutique injectable contenant l'acide ursodesoxycholique ou l'acide tauroursodesoxycholique, une base forte et du trometamol
JP9524071A JP2000509013A (ja) 1995-12-27 1996-12-26 ウルソデオキシコール酸またはタウロウルソデオキシコール酸、強塩基、およびトロメタモールを含む注射可能な薬学的組成物
CA002240266A CA2240266A1 (en) 1995-12-27 1996-12-26 Injectable pharmaceutical composition comprising ursodesoxycholic acid or tauroursodesoxycholic acid, a strong base and tromethamol
AU13803/97A AU1380397A (en) 1995-12-27 1996-12-26 Injectable pharmaceutical composition comprising ursodesoxycholic acid or tauroursodesoxycholic acid, strong base and tromethamol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT95MI002763A IT1282943B1 (it) 1995-12-27 1995-12-27 Composizione farmaceutica iniettabile__a base di acido ursodesossicoli co o tauroursodesossicolico

Publications (3)

Publication Number Publication Date
ITMI952763A0 ITMI952763A0 (it) 1995-12-27
ITMI952763A1 ITMI952763A1 (it) 1997-06-27
IT1282943B1 true IT1282943B1 (it) 1998-04-02

Family

ID=11372820

Family Applications (1)

Application Number Title Priority Date Filing Date
IT95MI002763A IT1282943B1 (it) 1995-12-27 1995-12-27 Composizione farmaceutica iniettabile__a base di acido ursodesossicoli co o tauroursodesossicolico

Country Status (7)

Country Link
US (1) US5955456A (it)
EP (1) EP0920320A2 (it)
JP (1) JP2000509013A (it)
AU (1) AU1380397A (it)
CA (1) CA2240266A1 (it)
IT (1) IT1282943B1 (it)
WO (1) WO1997024125A2 (it)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6596762B2 (en) 2001-05-17 2003-07-22 The Regents Of The University Of Colorado Antioxidant compositions and use for treatment of hepatic steatosis and steatohepatitis
TWI232102B (en) 2001-07-17 2005-05-11 Shionogi & Co A pharmaceutical formulation for injection
US9295677B2 (en) 2008-02-26 2016-03-29 Qing Bile Therapeutics Inc. Polyhydroxylated bile acids for treatment of biliary disorders
CA3157999A1 (en) 2019-11-22 2021-05-27 Pradeep SHIVAKUMAR Injectable compositions of ursodeoxycholic acid
WO2021152430A1 (en) * 2020-01-28 2021-08-05 Shilpa Medicare Limited Method for administration of ursodeoxycholic acid
CA3210908A1 (en) * 2021-02-15 2022-08-18 Santen Pharmaceutical Co., Ltd. Water-based pharmaceutical composition containing ursodeoxycholic acid or salt thereof
WO2024034592A1 (ja) * 2022-08-09 2024-02-15 参天製薬株式会社 Ｕｄｃａまたはその塩を含有する水性医薬組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2521430A1 (fr) * 1982-02-12 1983-08-19 Pan Medica Solution aqueuse d'acide ursodesoxycholique a usages therapeutiques, son procede de preparation et application au traitement des lithiases biliaires
US4649155A (en) * 1983-07-22 1987-03-10 Hoffmann-La Roche Inc. Injectable solutions
GB8706313D0 (en) * 1987-03-17 1987-04-23 Health Lab Service Board Treatment & prevention of viral infections
AU683049B2 (en) * 1993-03-31 1997-10-30 Mitsubishi-Tokyo Pharmaceuticals, Inc. Cholestasis ameliorant

Also Published As

Publication number Publication date
CA2240266A1 (en) 1997-07-10
ITMI952763A1 (it) 1997-06-27
AU1380397A (en) 1997-07-28
ITMI952763A0 (it) 1995-12-27
WO1997024125A2 (fr) 1997-07-10
EP0920320A2 (fr) 1999-06-09
WO1997024125A3 (fr) 1997-10-16
US5955456A (en) 1999-09-21
JP2000509013A (ja) 2000-07-18

Similar Documents

Publication Publication Date Title
FI944832A (fi) Farmaseuttinen koostumus
FI965202A0 (fi) Farmaseuttiset takriinikoostumukset
FI955144A0 (fi) Päällystetyt farmaseuttiset koostumukset
NO20004345L (no) Farmasøytisk sammensetning
FI955311A0 (fi) Farmaseuttinen koostumuspohja
DK0623580T3 (da) 2-Keto-3-methyl-4-hydroxy-valerianesyre
ITMI932540A0 (it) Composizione farmaceutica
EE9900545A (et) Farmatseutiline kompositsioon
ATE208364T1 (de) A-oxo-butansäuren enthaltende pharmazeutische zusammensetzung
IT1282943B1 (it) Composizione farmaceutica iniettabile__a base di acido ursodesossicoli co o tauroursodesossicolico
FI955605A0 (fi) Aryloivia lääkkeitä
FI973280A0 (fi) Farmaseuttinen koostumus
DE59402621D1 (de) Fluor-trifluormethylbenzoesäure-Derivate
LV10579A (lv) Farmaceitiska kompozicija
FI934387A0 (fi) 3-substituerade 2-oxi-indol-1-karboxiamid omfattande farmaceutiska kompositioner
BR9605777A (pt) Composição farmacêutica
BR9605131A (pt) Composição farmacêutica
DE69402721D1 (de) Markraumnagelsystem
ITMI932543A0 (it) Composizione farmaceutica
BR1100200A (pt) Composição farmacêutica
DK38393D0 (da) Nyt laegemiddel
SE9303385D0 (sv) Sammanfognings- spik
ITMI920122A1 (it) Composizioni farmaceutiche orali a base di n5-metiltetraidrofolato di calcio
NO931304D0 (no) Bordsammenfoeyer/spikrer
ITMI930181A1 (it) Composizione farmaceutica contenente n-acetil-cisteina

Legal Events

Date Code Title Description
0001 Granted